
Tom Powles and Neal Shore
Apr 29, 2025, 10:50
Tom Powles: Podcast with Neal Shore around the CREST RIII untreated NMIBC BCG +/- PD1 trial
Tom Powles, Professor at the University of London, shared a post on X:
“Here is a podcast with Neal Shore around the CREST RIII untreated NMIBC BCG +/- PD1 trial which show and EFS advantage but with expected immune related toxicity.
Here we discuss the highlights and risk benefit ratio.”
More posts featuring Tom Powles.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 29, 2025, 10:37
Apr 29, 2025, 10:28
Apr 29, 2025, 10:18
Apr 29, 2025, 10:16
Apr 29, 2025, 10:07
Apr 29, 2025, 09:54